SCHEMBL16355273

SCHEMBL16355273

c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4ccc(-c5c6ccccc6c(-c6cccc7ccccc67)c6ccccc56)cc4)cc3)c3ccc(-c4ccccn4)cc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.40
HTR2C P28335 2/20 0.39
KDM4E B2RXH2 5/20 0.39
HPGD P15428 4/20 0.39
ALDH1A1 P00352 4/20 0.39
TP53 P04637 4/20 0.39
HSD17B10 Q99714 3/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 3/20 0.39
MAPK1 P28482 2/20 0.39
TGFBR1 P36897 1/20 0.37
DCTPP1 Q9H773 1/20 0.36
TSHR P16473 2/20 0.35
LMNA P02545 3/20 0.33
RAB9A P51151 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15178583 0.93 HTR2C (0.41) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL15158412 0.92 KDM4E (0.42) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL15158403 0.91 MAPK1 (0.43) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL13231082 0.88 HPGD (0.34) HTR2CKDM4EHPGDALDH1A1TP53
SCHEMBL15178585 0.87 HTR2C (0.39) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL15158500 0.87 HTR2C (0.41) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL15237198 0.87 MAPT (0.40) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL16355266 0.86 CYP2A6 (0.46) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL15158450 0.85 KDM4E (0.41) DHODHHTR2CKDM4EHPGDALDH1A1
SCHEMBL15158508 0.85 KDM4E (0.41) DHODHHTR2CKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9825244-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-21 US disclosed
US-9825244-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-21 US disclosed
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2016-10-20 US disclosed
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2016-10-20 US disclosed
US-9385336-B2 Organic light-emitting device using a mixture of electron transporting compounds SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-05 US disclosed
US-9385336-B2 Organic light-emitting device using a mixture of electron transporting compounds SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-05 US disclosed
US-20140374713-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-25 US disclosed
US-20140374713-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE ELMO1, ESR2, ELP1 DHODH 2662/4885HTR2C 2485/4885KDM4E 3314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.